118 related articles for article (PubMed ID: 10069171)
1. [Estrogen and progestin treatment in postmenopause. Effects on the endometrium].
Grio R; Curti A; Gobbi F; Piacentino R
Minerva Ginecol; 1998 Dec; 50(12):553-6. PubMed ID: 10069171
[TBL] [Abstract][Full Text] [Related]
2. Transdermal progesterone cream as an alternative progestin in hormone therapy.
Leonetti HB; Landes J; Steinberg D; Anasti JN
Altern Ther Health Med; 2005; 11(6):36-8. PubMed ID: 16320858
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
4. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
[TBL] [Abstract][Full Text] [Related]
5. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
6. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis.
Wood CE; Clarkson TB; Chen H; Veenstra TD; Xu X; Scott L; Cline JM
Menopause; 2008; 15(5):890-8. PubMed ID: 18520696
[TBL] [Abstract][Full Text] [Related]
8. Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT.
Gibbons WE; Thorneycroft IH
J Reprod Med; 1999 Feb; 44(2 Suppl):203-8. PubMed ID: 11392033
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
[TBL] [Abstract][Full Text] [Related]
10. The new hormone therapy problem: do we solve it with long-cycle progesterone therapy?
Ravnikar V
Menopause; 2005; 12(6):664-7. PubMed ID: 16278608
[No Abstract] [Full Text] [Related]
11. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
12. Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy.
Crandall CJ; Karlamangla A; Huang MH; Ursin G; Guan M; Greendale GA
Arch Intern Med; 2006 Aug 14-28; 166(15):1578-84. PubMed ID: 16908790
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin.
Xing S; Wu Y; Liu J; Xu R; Zhang Z; Wang Y
Chin Med J (Engl); 2003 Apr; 116(4):584-7. PubMed ID: 12875727
[TBL] [Abstract][Full Text] [Related]
14. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
15. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone replacement therapy: endometrial and breast effects.
Yeh IT
Adv Anat Pathol; 2007 Jan; 14(1):17-24. PubMed ID: 17198307
[TBL] [Abstract][Full Text] [Related]
17. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
de Lignieres B
J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
[TBL] [Abstract][Full Text] [Related]
18. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
[TBL] [Abstract][Full Text] [Related]
19. Endometrial pathology and estrogens.
Rosenwaks Z; Wentz AC; Jones GS; Urban MD; Lee PA; Migeon CJ; Parmley TH; Woodruff JD
Obstet Gynecol; 1979 Apr; 53(4):403-10. PubMed ID: 220573
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study.
Kaari C; Haidar MA; Júnior JM; Nunes MG; Quadros LG; Kemp C; Stavale JN; Baracat EC
Maturitas; 2006 Jan; 53(1):49-58. PubMed ID: 16257151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
